The risk of new-onset type 2 diabetes and the influence of risk factors among men with prostate cancer in the Danish Diet, Cancer, and Health study
Overall, survivors of PCa should not be more concerned about T2DM than PCa-free men; first-line treatment does not change the overall risk of T2DM in survivors of PCa. However, cardiometabolic risk factors require awareness to mitigate the risk of T2DM.
Authors
- Signe Benzon Larsen (ORCID: https://orcid.org/0000-0001-9522-7678)
- Klaus Brasso (ORCID: https://orcid.org/0000-0001-6562-6416)
- Tinne Laurberg (ORCID: https://orcid.org/0000-0002-7555-2665)
- Anne Katrine Graudal Levinsen (ORCID: https://orcid.org/0000-0003-0906-1873)
- Susanne Oksbjerg Dalton (ORCID: https://orcid.org/0000-0002-5485-2730)
- Maja Halgren Olsen (ORCID: https://orcid.org/0000-0001-6027-5717)
- Gunn Ammitzbøll (ORCID: https://orcid.org/0000-0003-3227-9475)
- Anne Marie Tjønneland (ORCID: https://orcid.org/0000-0003-4385-2097)
- Jeppe Lyngbye Widding (ORCID: https://orcid.org/0009-0008-8736-7724)
- Monika Barsøe
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
- Danish Cancer Society (DK)
Publication Details
- Journal
- Journal of Cancer Survivorship
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1007/s11764-025-01776-7
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00